Progesterone
- Generic Name
- Progesterone
- Brand Names
- Bijuva, Crinone, Endometrin, Prochieve, Prometrium
- Drug Type
- Small Molecule
- Chemical Formula
- C21H30O2
- CAS Number
- 57-83-0
- Unique Ingredient Identifier
- 4G7DS2Q64Y
- Background
Progesterone is a hormone that occurs naturally in females, and is essential for endometrial receptivity, embryo implantation, and the successful establishment of pregnancy. A low progesterone concentration or an insufficient response to progesterone can cause infertility and pregnancy loss . Progesterone is used in various contraceptive preparations to prev...
- Indication
Gelatinized capsules
The gelatinized capsules are indicated for use in the prevention of endometrial hyperplasia in non-hysterectomized postmenopausal women who are receiving conjugated estrogens tablets. They are also indicated for use in secondary amenorrhea .
Vaginal gel
...
- Associated Conditions
- Abnormal Uterine Bleeding, Amenorrhea, Endometrial hyperplasia caused by conjugated estrogen, Moderate to Severe Vasomotor Symptoms, Pregnancy, Secondary Amenorrhea, Recurrent spontaneous preterm birth
- Associated Therapies
- Assisted Reproductive Technology therapy
Oral Versus Vaginal Progesterone in the Luteal Support in Cryo-warmed Embryo Transfer Cycles
- First Posted Date
- 2018-08-08
- Last Posted Date
- 2023-07-20
- Lead Sponsor
- American University of Beirut Medical Center
- Target Recruit Count
- 157
- Registration Number
- NCT03619707
- Locations
- 🇱🇧
American University of Beirut Medical Center, Beirut, Lebanon
Vaginal Progesterone for the Prevention of Preterm Birth in Twins
- First Posted Date
- 2018-05-30
- Last Posted Date
- 2021-01-28
- Lead Sponsor
- Chiu Yee Liona Poon
- Registration Number
- NCT03540225
- Locations
- 🇭🇰
Queen Elizabeth Hospital, Hong Kong, Hong Kong
🇭🇰Princess Margaret Hospital, Hong Kong, Hong Kong
🇭🇰Kwong Wah Hospital, Hong Kong, Hong Kong
Progesterone Supplementation in Frozen Embryo Transfer Cycles
- First Posted Date
- 2018-04-20
- Last Posted Date
- 2018-04-20
- Lead Sponsor
- Mount Sinai Hospital, Canada
- Target Recruit Count
- 240
- Registration Number
- NCT03504345
Prediction of Metaphase II Oocytes According to Different Levels of Serum AMH in Poor Responders Using the Antagonist Protocol
- Conditions
- Interventions
- First Posted Date
- 2018-04-02
- Last Posted Date
- 2018-04-02
- Lead Sponsor
- Cairo University
- Target Recruit Count
- 179
- Registration Number
- NCT03484611
- Locations
- 🇪🇬
Kasr Alainy medical school, Cairo, Egypt
Administration of Vaginal and Rectal Progesterone During FET Cycles
- Conditions
- First Posted Date
- 2018-03-20
- Last Posted Date
- 2019-09-10
- Lead Sponsor
- Thor Haahr
- Target Recruit Count
- 277
- Registration Number
- NCT03470610
- Locations
- 🇩🇰
Fertility Clinic Regional Hospital Skive, Skive, Denmark
Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC
- Conditions
- Interventions
- First Posted Date
- 2018-03-13
- Last Posted Date
- 2021-09-13
- Lead Sponsor
- West China Second University Hospital
- Target Recruit Count
- 224
- Registration Number
- NCT03463252
- Locations
- 🇨🇳
West China Second University Hospital, Chengdu, Sichuan, China
Progesterone for Cannabis Withdrawal
- Conditions
- Interventions
- First Posted Date
- 2018-02-12
- Last Posted Date
- 2019-05-22
- Lead Sponsor
- Medical University of South Carolina
- Target Recruit Count
- 8
- Registration Number
- NCT03430050
- Locations
- 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States
Non-interventional Study of Therapy for Threatened Miscarriage
- Conditions
- Interventions
- First Posted Date
- 2017-10-16
- Last Posted Date
- 2018-01-18
- Lead Sponsor
- Besins Healthcare
- Target Recruit Count
- 1241
- Registration Number
- NCT03309735
- Locations
- 🇷🇺
Regional perinatal center, Kursk, Kursk Region, Russian Federation
🇷🇺City Clinical Hospital of the Demsk District, Ufa, Bashkortostan Republic, Russian Federation
🇷🇺Сity hospital №7, Samara, Samara Region, Russian Federation
Canadian Study on the Association of Pessary With Progesterone
- Conditions
- Interventions
- First Posted Date
- 2017-07-24
- Last Posted Date
- 2023-04-06
- Lead Sponsor
- Université de Sherbrooke
- Target Recruit Count
- 79
- Registration Number
- NCT03227705
- Locations
- 🇨🇦
Centre hospitalier de l'Université de Montréal, Montréal, Quebec, Canada
🇨🇦CHU de Québec-Université Laval, Quebec city, Quebec, Canada
🇨🇦Ottawa Hospital, Ottawa, Ontario, Canada
Vaginal Progesterone Supplementation in the Management of Preterm Labor
- Conditions
- Interventions
- First Posted Date
- 2017-06-29
- Last Posted Date
- 2019-01-31
- Lead Sponsor
- Chulalongkorn University
- Target Recruit Count
- 90
- Registration Number
- NCT03202836
- Locations
- 🇹🇭
Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.